<DOC>
	<DOC>NCT00894530</DOC>
	<brief_summary>The objective of this study is to compare the safety and efficacy of azithromycin ophthalmic solution, 1% versus placebo over a four-week treatment period.</brief_summary>
	<brief_title>The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638)</brief_title>
	<detailed_description />
	<mesh_term>Blepharitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Have best corrected visual acuity in both eyes of at least +0.7 or better If female, are nonpregnant or nonlactating Have a current diagnosis of blepharitis in one or both eyes Have lid structural abnormalities Have suspected ocular fungal or viral infection Have practiced warm compress therapy within 14 days prior to Visit 2 Unable to withhold the use of contact lenses during the treatment or followup periods Unable to withhold the use of ocular cosmetic products within 24 hours prior to study visits Have had penetrating intraocular surgery within 90 days prior to Visit 2 Have had ocular surface surgery within the past year prior to Visit 2 Have a serious medical condition which could confound study assessments</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>